Bliss GVS Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)

Strategic Transactions View source PDF Explain this filing

BLISSGVS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹217.90

prior close

₹214.84

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.5%+0.6% vs market

Pharmaceuticals peers, median of 156sector-0.9%-0.0% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.1

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9-1.5+0.6-0.9-0.0

Next day

+1.4-2.2+3.6-1.5+2.9

+6.2-1.2+7.4-0.9+7.1

+5.5-0.9+6.4-0.5+6.0

+3.7-2.3+6.1-2.1+5.8

+2.6-2.5+5.1-2.3+4.9

-1.9-3.6+1.7-3.2+1.3

15d

-6.1-10.4+4.3-6.9+0.8

-6.8-11.3+4.5-8.9+2.1

+19.8-3.6+23.3-3.5+23.3

+28.6+3.9+24.7+0.8+27.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

A news item on CNBC आवाज़ on February 13, 2026 reported that Bliss GVS Pharma may acquire Anupam Rasayan. The company has formally clarified that this news item is purely speculative and did not originate from any official communication from the company. As of date, the promoters have not made, finalised, or approved any decision or arrangement regarding this matter. The company stated that no information currently warrants disclosure under SEBI's Listing Regulations. Investors have been advised to rely only on official disclosures made by the company to the stock exchanges.

Likely market impact

This is a denial of an acquisition rumor, which may help calm any speculative trading in the stock triggered by the CNBC report. Shareholders should treat the rumored acquisition as unconfirmed and not act on it until an official announcement is made by the company.